HARTFORD — A key legislative committee has a dilemma. It has to approve legislation that some members vehemently oppose.
More than a year after Consumer Protection Commissioner Jonathan Harris confirmed the first of several new ailments to qualify for the state’s medical-marijuana program, lawmakers next week have to do their jobs and endorse the expansion of patient eligibility.
The bipartisan Regulation Review Committee, which has dual Republican and Democratic co-chairmen, will meet on Tuesday and can delay action for 60 days. But after several public hearings last year, approval by the Board of Physicians that advises Harris, review by the department’s lawyers as well the state attorney general, the new regulations are likely to be adopted.
Read more
